| Term 
 | Definition 
 
        | Phenobarbital (Nembutal) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Misc CNS Depressant Prototype |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Contraindications to alprolazam therapy |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Contraindications to Chlorpromazine (Thorazine) |  | Definition 
 
        | Alcohol w/d, comatose, Reyes syndrome, lactation |  | 
        |  | 
        
        | Term 
 
        | S/E of Phenothiazines (Anti-psychotic) |  | Definition 
 
        | Extrapyramidal, Neuroepileptic Malignant Syndrome (NMS), orthostatic HTN |  | 
        |  | 
        
        | Term 
 
        | Phenothyazine Patient Teaching |  | Definition 
 
        | baseline vitals, underlying disorders, report EPS or NMS, document daily dose on calendar, do stop abruptly |  | 
        |  | 
        
        | Term 
 
        | Nonphenothiazine Prototype |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Atypical Antipsychotic Prototype (Drug of Choice for Schiz)
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clozapine Adverse Effects |  | Definition 
 
        | Agranulocytosis, seizures, dizziness, fever, salivation, flu-like symptoms, tachycardia |  | 
        |  | 
        
        | Term 
 
        | TCA Prototype - inhibits reuptake of serotonin and norepinephrine |  | Definition 
 
        | Amitriptyline (Elavil), Imipramine (Trofanil) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Orthostatic Hypotension, insomnia, diarrhea, tyramine interaction |  | 
        |  | 
        
        | Term 
 
        | SSRI Prototype Selectively targets serotonin reuptake
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SSRI S/E - greater safety |  | Definition 
 
        | Sexual dysfunction, nausea, weight gain, anxiety, insomnia, SES |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dry mouth, blurred vision, urinary retention, constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased heart rate and hypertension |  | 
        |  | 
        
        | Term 
 
        | SS of Withdrawal from BZDs |  | Definition 
 
        | Anxiety, tremors, respiratory depression, death |  | 
        |  | 
        
        | Term 
 
        | Mood Stabilizer Prototype Treatment for Bipolar Disorder
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vomiting, diarrhea, slurred speech, decreased coordination, muscle weakness, twitching |  | 
        |  | 
        
        | Term 
 
        | MAOI/tyrmine interaction reversal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bile Acid Resins Administration |  | Definition 
 
        | Give one hr before, 4-6 after other meals, mix w cool liquids, |  | 
        |  | 
        
        | Term 
 
        | Lithium S/E (acts like sodium) |  | Definition 
 
        | Dizziness, fatigue, s/t memory loss, increased urination, dry mouth, loss of appetite |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Do not avoid salt (reduces drug secretion), keep all lab visits, changes in diet or fluid intake can effect levels, avoid ETOH, OTC and herbals, drink plenty of fluids |  | 
        |  | 
        
        | Term 
 
        | Atypical antipsychotic S/E (Drug of choice for Schizophrenia)
 |  | Definition 
 
        | Leukopenia and agranulocytis, osteoporosis, decreased libido, weight gain, do not cause EPS |  | 
        |  | 
        
        | Term 
 
        | BZD Reversal drug (antagonist) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Orthostatic Hypotension, sedation, anticholinergic, seizures, sexual dysfuntion |  | 
        |  | 
        
        | Term 
 
        | Antihyperlipidemic - HMG-CoA reductase inhibitors
 |  | Definition 
 
        | Statins - First line of treatment |  | 
        |  | 
        
        | Term 
 
        | Class - Statins (think "liver") Inhibits cholesterol production
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rhabdomyolysis (break down of skeletal tissue), weakness and pain, abdominal cramps, elevated liver enzymes, interact with graprefruit |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Take w/food, report muscle pain/weakness, avoid acohol and grapefruit |  | 
        |  | 
        
        | Term 
 
        | Class - Bile Acid Resins(binds to bile acids and makes them too large to be absorbed) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Niacin - high dose of Vitamin B3 |  | 
        |  | 
        
        | Term 
 
        | Class - Fibric Acid Agents (DO NOT GIVE WITH STATINS)
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anticoagulants - Prevents Clot formation (II, VII, IX, X) |  | Definition 
 
        | Coumadin, Heparin prevent Venous thrombi from enlarging; do not lyse clots, are not blood thinners
 |  | 
        |  | 
        
        | Term 
 
        | Coumadin (anti-coagulant) |  | Definition 
 
        | inhibits sythesis of vitamin K dependent clotting factors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | INR (2.0 - 3.5) and PT (1-2x pt baseline) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | No systemic effects, gas, NVD, vitamin absorption deficiency (take multivitamin) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Many drugs, ETOH, antibiotics |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Avoid alcohol, consume consisten amts of vitamin K, lab work |  | 
        |  | 
        
        | Term 
 
        | Heparin (anticoagulant)mech of action |  | Definition 
 
        | Low dose prevents conversion of prothrombin to thrombin; high dose prevent conversion of fibrinogen to fibrin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sub Q or IV, quicker onset |  | 
        |  | 
        
        | Term 
 
        | Heparin lab and therapeutic level |  | Definition 
 
        | aPTT; 1.2 - 2.5 baselin aPTT; 20-45 seconds, monitor plateletts for HIT, wrong dose can be fatal for peds |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Concurrent w/LMWH (fatal), thrombocytepnia |  | 
        |  | 
        
        | Term 
 
        | Low Molecular Weight Heparin (LMWT) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anticoagulants considerations |  | Definition 
 
        | same time every day, assess for bleeding, transition from Heparin to Coumadin, both taken for 2-3 days, avoid ASA or NSAIDS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ASA (Aspirin) ADP Receptor blockers (Plavix)
 |  | 
        |  | 
        
        | Term 
 
        | Antiplatelet action (arterial circulation) |  | Definition 
 
        | prevents platelette aggregation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bleeding, neutropenia, TTP (clots forming everywhere) |  | 
        |  | 
        
        | Term 
 
        | Antiplatet considerations (dose 325 mg) |  | Definition 
 
        | monitor CBC, Avoid ASA and NSAIDS |  | 
        |  |